ArticleInternational journal of clinical pediatric dentistry2024
EvoraPlus Oral Probiotic Tablet: New paradigm for Caries Prevention in Children.
Article in International journal of clinical pediatric dentistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: According to the World Health Organization, probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. The use of oral probiotics in children to improve oral health may lead to nonpathogenic bacteria replacing cariogenic bacteria. The Evora Plus oral probiotics tablet is the first such oral probiotics tablet containing a proprietary blend of three select species of naturally occurring oral bacteria, each with a specific function for maintaining a healthy oral environment. These strains include Aim: To compare the levels of salivary total bacterial count, salivary pH levels, and salivary Materials and methods: Around 40 caries-free schoolchildren from Daksh International School, Gadarwara, Madhya Pradesh, India, aged 12-14 years, were selected and divided equally into two groups-group A, in which total salivary bacterial count and pH were evaluated, and group B, in which salivary Results: The study showed a significant reduction in salivary total bacterial count and salivary Conclusion: Cariogenic microorganisms could be reduced by an oral probiotic formulation. Thus, the use of the Evora Plus oral probiotic tablet could be recommended for the prevention of enamel demineralization. How to cite this article: Mishra A, Saurabh S. EvoraPlus Oral Probiotic Tablet: New paradigm for Caries Prevention in Children. Int J Clin Pediatr Dent 2024;17(9):1044-1048.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.